Constitutive hyperdopaminergia is functionally associated with reduced behavioral lateralization

Neuropsychopharmacology

Volumn 30, Issue 3, 2005, Pages 575-581

  Morice, Elise ^a   Denis, Cécile ^a   Macario, Alessandro ^a   Giros, Bruno ^a   Nosten Bertrand, Marika ^a  

^a INSERM   (France)

Author keywords

Cocaine; Direction and degree of asymmetry; Knockout mice; Paw preference; Schizophrenia

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACKCROSSING; CONSTITUTIVE HYPERDOPAMINERGIA; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HANDEDNESS; HEMISPHERIC DOMINANCE; HYPOTHESIS; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE STRAIN; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FUNCTIONAL LATERALITY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; REACTION TIME; TIME FACTORS;

EID: 13944252144     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300570     Document Type: Article

References (47)

1. Atchley WR, Fitch WM (1991). Gene trees and the origins of inbred strains of mice. Science 254: 554-558.
2. Betancur C, Neveu PJ, Le Moal M (1991). Strain and sex differences in the degree of paw preference in mice. Behav Brain Res 45: 97-101.
3. Biddle FG, Coffaro CM, Ziehr JE, Eales BA (1993). Genetic variation in paw preference (handedness) in the mouse. Genome 36: 935-943.
4. Biddle FG, Eales BA (1996). The degree of lateralization of paw usage (handedness) in the mouse is defined by three major phenotypes. Behav Genet 26: 391-406.
5. Cabib S, D'Amato FR, Neveu PJ, Deleplanque B, Le Moal M, Puglisi AS (1995). Paw preference and brain dopamine asymmetries. Neuroscience 64: 427-432.
6. Cannon M, Jones P, Murray RM, Wadsworth ME (1997). Childhood laterality and later risk of schizophrenia in the 1946 British birth cohort. Schizophr Res 26: 117-120.
7. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G (2001). Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21: 1-4.
8. Carlsson A, Lindqvist M (1963). Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20: 140-144.
9. Collins RL (1975). When left-handed mice live in right-handed worlds. Science 187: 181-184.
10. Collins RL (1985). On the inheritance of direction and degree of asymmetry. In: Glick SD (ed). Cerebral Lateralization in Nonhuman Species. Academic Press: London. pp 41-71.
11. Collins RL (1991). Reimpressed selective breeding for lateralization of handedness in mice (published erratum appears in Brain Res 1992;573(2):359). Behav Brain Res 45: 135-145.
12. Collins RL (1991). Reimpressed selective breeding for lateralization of handedness in mice (published erratum appears in Brain Res 1992;573(2):359). Behav Brain Res 45: 135-145.
13. Crow TJ, Done DJ, Sacker A (1996). Cerebral lateralization is delayed in children who later develop schizophrenia. Schizophr Res 22: 181-185.
14. David A, Malmberg A, Lewis G, Brandt L, Allebeck P (1995). Are there neurological and sensory risk factors for schizophrenia? Schizophr Res 14: 247-251.
15. Denenberg VH, Sherman GF, Schrott LM, Rosen GD, Galaburda AM (1991). Spatial learning, discrimination learning, paw preference and neocortical ectopias in two autoimmune strains of mice. Brain Res 562: 98-104.
16. Gainetdinov RR, Caron MG (2003). Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43: 261-284.
17. Gainetdinov RR, Mohn AR, Caron MG (2001). Genetic animal models: focus on schizophrenia. Trends Neurosci 24: 527-533.
18. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283: 397-401.
19. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612.
20. Grunder G, Vernaleken I, Muller MJ, Davids E, Heydari N, Buchholz HG et al (2003). Subchronic haloperidol down-regulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology 28: 787-794.
21. Gruzelier JH (1999). Functional neuropsychophysiological asymmetry in schizophrenia: a review and reorientation. Schizophr Bull 25: 91-120.
22. Hietala J, Syvalahti E, Vilkman H, Vuorio K, Rakkolainen V, Bergman J et al (1999). Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res 35: 41-50.
23. Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M et al (1995). Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346: 1130-1131.
24. Hsiao MC, Lin KJ, Liu CY, Tzen KY, Yen TC (2003). Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1. Schizophr Res 65: 39-46.
25. Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ et al (1999). Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2: 649-655.
26. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998). Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95: 4029-4034.
27. Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O et al (2000). Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. Am J Psychiatry 157: 269-271.
28. Leboyer M, Bellivier F, Nosten-Bertrand M, Jouvent R, Pauls D, Mallet J (1998). Psychiatric genetics: search for phenotypes. Trends Neurosci 21: 102-105.
29. Mead AN, Rocha BA, Donovan DM, Katz JL (2002). Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. Eur J Neurosci 16: 514-520.
30. Morice E, Denis C, Giros B, Nosten-Bertrand M (2004). Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci 20: 120-126.
31. Nielsen DM, Visker KE, Cunningham MJ, Keller RJ, Glick SD, Carlson JN (1997). Paw preference, rotation, and dopamine function in Collins HI and LO mouse strains. Physiol Behav 61: 525-535.
32. Nosten M, Roubertoux P, Degrelle H, Leboyer M (1989). Effect of the Tfm mutation on handedness in mice. J Endocrinol 121: R5-R7.
33. Puglisi-Allegra S, Cabib S (1997). Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice. Prog Neurobiol 51: 637-661.
34. Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA (2001). Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci 21: 305-313.
35. Rodriguiz RM, Chu R, Caron MG, Wetsel WC (2004). Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res 148: 185-198.
36. Satz P, Green MF (1999). Atypical handedness in schizophrenia: some methodological and theoretical issues. Schizophr Bull 25: 63-78.
37. Signore P, Chaoui M, Nosten BM, Perez DF, Marchaland C (1991a). Handedness in mice: comparison across eleven inbred strains. Behav Genet 21: 421-429.
38. Signore P, Nosten-Bertrand M, Chaoui M, Roubertoux PL, Marchaland C, Perez-Diaz F (1991b). An assessment of handedness in mice. Physiol Behav 49: 701-704.
39. Snyder SH (1976). The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry 133: 197-202.
40. Sommer I, Ramsey N, Kahn R, Aleman A, Bouma A (2001). Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. Br J Psychiatry 178: 344-351.
41. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB et al (2001). Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98: 5300-5305.
42. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R et al (1998). Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95: 7699-7704.
43. Spielewoy C, Gonon P, Roubert C, Fauchey V, Jaber M, Caron MG et al (2000a). Increased rewarding properties of morphine in dopamine-transporter knockout mice (in process citation). Eur J Neurosci 12: 1827-1837.
44. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B (2000b). Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol 11: 279-290.
45. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994). Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51: 139-154.
46. Torres GE, Gainetdinov RR, Caron MG (2003). Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4: 13-25.
47. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004). Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305: 217.